1. Brucella melitensis omp31 Mutant Is Attenuated and Confers Protection Against Virulent Brucella melitensis Challenge in BALB/c Mice
- Author
-
R Oropeza-Navarro, Adolfo Ortiz, Antonio Verdugo-Rodríguez, M G Robles-Pesina, J Ramírez-Lezama, L Verdiguel-Fernández, and A Castañeda-Ramírez
- Subjects
biology ,Strain (chemistry) ,Mutant ,Virulence ,Spleen ,Brucellosis ,General Medicine ,biology.organism_classification ,medicine.disease ,Applied Microbiology and Biotechnology ,BALB/c ,Microbiology ,medicine.anatomical_structure ,Immunity ,medicine ,Biotechnology ,Brucella melitensis - Abstract
For control of brucellosis in small ruminants, attenuated B. melitensis Rev1 is used but it can be virulent for animals and human. Based on these aspects, it is essential to identify potential immunogens to avoid these problems in prevention of brucellosis. The majority of OMPs in the Omp25/31 family have been studied because these proteins are relevant in maintaining the integrity of the outer membrane but their implication in the virulence of the different species of this genus is not clearly described. Therefore, in this work we studied the role of Omp31 on virulence by determining the residual virulence and detecting lesions in spleen and testis of mice inoculated with the B. melitensis LVM31 mutant strain. In addition, we evaluated the conferred protection in mice immunized with the mutant strain against the challenge with the B. melitensis Bm133 virulent strain. Our results showed that the mutation of omp31 caused a decrease in splenic colonization without generating apparent lesions or histopathological changes apparent in both organs in comparison with the control strains and that the mutant strain conferred similar protection as the B. melitensis Rev1 vaccine strain against the challenge with B. melitensis Bm133 virulent strain. These results allow us to conclude that Omp31 plays an important role on the virulence of B. melitensis in the murine model, and due to the attenuation shown by the strain, it could be considered a vaccine candidate for the prevention of goat brucellosis.
- Published
- 2020